Gleason Score News and Research

RSS
Seven elevated biomarkers predict prostate cancer risk with 86.6 percent reliability

Seven elevated biomarkers predict prostate cancer risk with 86.6 percent reliability

Radiation therapy prolongs life in men with recurrent prostate cancer

Radiation therapy prolongs life in men with recurrent prostate cancer

Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer

Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer

Additional biopsy-scoring data may help determine prostate cancer prognosis

Additional biopsy-scoring data may help determine prostate cancer prognosis

Stereotactic body radiation therapy reduces length of prostate cancer treatment

Stereotactic body radiation therapy reduces length of prostate cancer treatment

Black men do not have more aggressive prostate cancer

Black men do not have more aggressive prostate cancer

Finasteride unlikely to induce high grade prostate cancers

Finasteride unlikely to induce high grade prostate cancers

High pretreatment PSA velocity predicts worse outcome

High pretreatment PSA velocity predicts worse outcome

Smoking associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

Smoking associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

Report on radical prostatectomy for octogenarians

Report on radical prostatectomy for octogenarians

New way to identify which men need a second prostate biopsy

New way to identify which men need a second prostate biopsy

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Long-term oncologic outcomes: A 40 year radical prostatectomy single institution series

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

New diagnostic tool for prostate cancer

New diagnostic tool for prostate cancer

A new diagnostic tool for prostate cancer

A new diagnostic tool for prostate cancer

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Shift in prostate cancer Gleason grades from 1989 to 2001

Shift in prostate cancer Gleason grades from 1989 to 2001

Monitoring anemia provides clues to prostate cancer treatment response

Monitoring anemia provides clues to prostate cancer treatment response